Hereditary Angioedema — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Hereditary angioedema type I
Hereditary angioedema (HAE) type I (85% of cases) is characterised by low C1 esterase inhibitor levels AND low C4. Type II has normal levels but dysfunctional C1 inhibitor (low C4, normal C1-INH level, low functional assay). HAE presents with recurrent episodes of angioedema without urticaria, affecting the face, extremities, GI tract (causing abdominal pain), and potentially the larynx (life-threatening). It is autosomal dominant (SERPING1 mutation). C4 is low both during and between attacks, making it a useful screening test. Acute treatment includes C1 inhibitor concentrate, Icatibant (bradykinin B2 receptor antagonist), or Ecallantide.
Reference: BAD 2019; BSACI 2017 HAE Guidelines